Health & Fit: The FDA may soon give women more options for boosting their libidos - - PressFrom - US
  •   
  •   
  •   

Health & FitThe FDA may soon give women more options for boosting their libidos

19:51  24 june  2019
19:51  24 june  2019 Source:   msn.com

'Women have no idea it's coming': What to know about perimenopause

'Women have no idea it's coming': What to know about perimenopause There’s lots of talk about the effects of menopause, but the years leading up to it can make women miserable, too.

June 21, 2019. WELL, THIS IS THE 21ST CENTURY, YOU KNOW: The FDA may soon give women more options for boosting their libidos .

The FDA may soon give women more options for boosting their libidos . Have a newsworthy tip? Share it with us. Oracle women fight for class-action status in gender pay lawsuit.

The FDA may soon give women more options for boosting their libidos© Ridofranz/Getty Images More than two decades after Viagra revolutionized the treatment of men's sexual health, women looking for a pharmaceutical boost in the bedroom are having another kind of Me Too moment.

In the coming days, the Food and Drug Administration is expected to decide whether to approve a new medication for pre-menopausal women whose flagging libidos are causing them personal distress.

If permitted to be sold in the U.S., the injectable drug Vyleesi would become just the second FDA-approved treatment for "female hypoactive sexual desire disorder," or HSDD. The condition, which was recognized in its gender-specific form only in 2012, is thought to affect as many as 1-in-10 women before the onset of menopause, and many more after that.

Air Italy becomes first European airline to offer non-binary booking options

Air Italy becomes first European airline to offer non-binary booking options Air Italy has become the first airline in Europe to introduce non-binary gender options for travelers who don't define themselves as male or female. 

The FDA may soon give women more options for boosting their libidos . More than two decades after Viagra revolutionized the treatment of men's sexual health, women looking for a pharmaceutical boost in the bedroom are having another kind of Me Too moment.

The FDA may soon give women more options for boosting their libidos . Locking up kids damages their mental health and leads to more disadvantage. Is this what we want?

The approval of Vyleesi (also known by its generic name bremelanotide) would leave the number of pharmaceutical options for women's sexual health far short of the more than two-dozen drugs approved for men. But several more offerings for women experiencing sexual troubles are waiting in the wings. And in marketing materials, backers are not shy about suggesting these drugs have "blockbuster potential."

It's a "huge market with unmet medical need," said Eric Claassen, chief business officer of the Dutch firm Emotional Brain, which expects to bring a pair of female HSDD drugs to the FDA by 2023. Potential sales for his firm's "personalized medicine" drugs, Lybrido and Lybridos, could peak at $2 billion, he said. Both are still in clinical trials and expected to be approved for marketing in Europe first.

Immune-Boosting Turmeric Golden Milk Daal

Immune-Boosting Turmeric Golden Milk Daal When we're feeling blah, dinner calls for a hug in a bowl. Liz Moody’s immune-boosting turmeric golden milk daal is just what the doctor ordered. “It has plenty of anti-inflammatory, immune-boosting spices, like ginger, turmeric and cinnamon, but the real secret is the garlic,” writes Moody. “When garlic is chopped and left to sit for 20 minutes, an enzymatic reaction occurs that makes it one of the most potent antiviral and antibacterial agents around.” Make sure you add the garlic after the daal is done cooking, but while it’s still warm.

If a person wants to boost their libido , there are many methods they can try, including lifestyle, diet, remedies, and sex tips. Here, we look at ways to boost Libido , or sex drive, naturally varies between individuals. Having a low sex drive is not necessarily a problem, but if a person wishes to boost their

The FDA may soon give women more options for boosting their libidos . Medical research. Advanced computational modeling of the gut for biodefense. Immunology. Bacteria live on our eyeballs—and understanding their role could help treat common eye diseases. Medications.

Vyleesi is the first investigational drug to be evaluated on measures that view women's sexual function - and dysfunction - as sharply different than men's.

Based on a compound first explored as a tanning product, bremelanotide is thought to amp up a woman's desire by changing the mix of neurochemicals involved in female sexual arousal.

But "thought to" is the key phrase here. As the FDA discovered in 2015, when it approved a pill called Addyi (fibanserin) as the first drug for female HSDD, controversy and questions abound when female sexual desire becomes the object of measurement, medicalization and pharmaceutical modification.

Vyleesi's sponsor, AMAG Pharmaceuticals of Waltham, Mass., hopes their product will put an end to those debates. Not only is their medication superior to the one on the market now, AMAG says, women's sexual concerns are better understood and the FDA's deliberations better reflect women's needs.

How long does it really take to get pregnant?

How long does it really take to get pregnant? You want to have a baby. Will it take weeks to get pregnant? Months? Years? Doctors explain.

Bremelanotide becomes the second FDA -approved drug for hypoactive sexual desire disorder in premenopausal women . Bremelanotide was studied in two replicate phase 3 trials with more than 600 patients each, testing for both increase in desire and reduction in distress, the hallmarks of HSDD.

Today’s approval provides women with another treatment option ,” U.S For example, many women have dealt with sexual trauma,” said Christian Jordal, a family and sex therapist at Drexel University. HSDD is estimated to affect 10 percent of premenopausal women , and many more after menopause.

The times have changed, too. Thanks to the Me Too movement, women are claiming more control over their bodies and their sexuality, said Dr. Julie Krop, the company's vice president and chief scientific officer. When that part of their lives falls short, they want to discuss it with their doctors and fix it, she said.

"It's shocking that this has been such a buried topic, taken for granted and not really valued," Krop said.

By making common cause with women's sexual health specialists, company officials helped shape the new measures by which the FDA would judge female sexuality drugs coming to market. And they have primed the public with a campaign of mass persuasion.

Long before the FDA's decision was scheduled, AMAG sponsored billboards, online forums and social media campaigns to spread the word about female hyposexual desire disorder through its unblush campaign. Radiological scans suggest it can be caused by an imbalance of certain hormones and neurotransmitters in the brain.

"It's not 'down there.' It's 'up here,' between your ears," the campaign materials explain without making reference to Vyleesi.

In US 1st, baby is born from deceased donor's transplanted womb

In US 1st, baby is born from deceased donor's transplanted womb The Cleveland Clinic says it has delivered the first baby in North America after a womb transplant from a dead donor. 

The FDA may soon give women more options for boosting their libidos . More than two decades after Viagra revolutionized the treatment of men's sexual health, women looking for a pharmaceutical boost in the bedroom are having another kind of Me Too moment.

FDA Approves First Drug to Boost Women ’s Sex Drive. An “Even the Score” petition urging the FDA to approve a drug for women with low libido collected more than 60,000 signatures. Some doctors might consider prescribing Addyi to women who have trouble getting an orgasm, Althof says

Drug-companies' yearly spending on such "disease awareness" campaigns has risen sharply in recent years, reaching $430 million in 2016. They're credited with lowering the stigma attached to many conditions, including depression and erectile dysfunction.

But by the measures FDA uses to determine the effectiveness of HSDD drugs, bremelanotide appears promising: in a final round of clinical trials, 60% of subjects taking bremelanotide reported improvement in the distress levels they felt over their low libido - a significant increase over the roughly one-third of women taking placebo medication.

AMAG is counting on Vyleesi to gain more traction with women and doctors than has Addyi, a medication that was shown in clinical trials to modestly increase women's sexual desire and the number of "sexually satisfying events" they reported in a month.

Since its 2015 approval, Addyi's commercial appeal has been limited not only by those modest claims of effectiveness, but by lingering safety concerns and cost as well. Women must take the medication daily, at a cost of as much as $426 a month. And while the FDA recently loosened warnings against any alcohol consumption by women taking Addyi, it has warned that the drug should not be used within two hours of alcohol consumption.

What Is Secondary Infertility, and What Can You Do About It?

What Is Secondary Infertility, and What Can You Do About It? Getting pregnant the second time around isn't always easy. What Is Secondary Infertility? Still, maybe you're one of those lucky people who get pregnant the first go at it, or within a few months. Everything goes smoothly until you start trying for a second baby…and nothing happens. Secondary infertility, or an inability to get pregnant after easily conceiving a first baby, isn't as commonly discussed as primary infertility—but it affects an estimated three million women in the U.S.

WASHINGTON (AP) — U.S. women will soon have another drug option designed to boost low sex drive: a shot they can give The FDA approved the new drug , Vyleesi (pronounced vie-LEE’-see), for premenopausal women The women didn’t report having more sex, the original goal for the drug .

Women and their doctors will have to decide whether the drug 's modest benefits warrant taking a psychiatric pill on a daily basis. The FDA specifically approved the drug for premenopausal women with hypoactive sexual desire disorder, described as a lack of sexual appetite that causes emotional

As an "on demand" drug - one designed to be taken only when women want to want sex - Vyleesi is likely to be less expensive than flibanserin, and to have fewer interactions with other drugs women take. While an earlier intranasal formulation of Vyleesi appeared to raise some women's blood pressure, the company has told the FDA that in its new injectable form, no such side effects have been found.

Dr. Sharon J. Parish, former president of the International Society for the Study of Women's Sexual Health, has prescribed Addyi and found it effective for some of her patients. But the ways in which women's sex lives can get off track are many, and women and their doctors need more options that work differently, she said.

"Bremelanotide's availability will offer a new approach," Parish said. "There's a select group of patients for whom enhancing certain neurotransmitters is just what they need to kick-start a complex process. I think it's a good time to be in the field of sexual medicine."

Visit the Los Angeles Times at www.latimes.com

Gallery: 10 surprising things that could be affecting your libido (Purple Clover)

The FDA may soon give women more options for boosting their libidos
Read More

Pros say there are major skin-boosting benefits to working out your face.
Thanks to the advances in technology, you can take the same principles that you apply to building muscles in your regular workouts and apply them to your complexion. One of the most effective ways to do this is with a micro-current device, which uses soft-wave technology to target deeper within skin. In fact, research presented in JAMA Dermatology found that working out the face helped to improve facial fullness. require(["medianetNativeAdOnArticle"], function (medianetNativeAdOnArticle) { medianetNativeAdOnArticle.

—   Share news in the SOC. Networks

Topical videos:

usr: 0
This is interesting!